AKT1 and colorectal carcinoma: We revealed for the first time that cincumol could efficiently inhibit the development of CRC in vitro through attenuating the PI3K/AKT signaling pathway, followed by the inhibition of tumor cell growth and migration, as well as the promotion of cell apoptosis.